These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25000442)

  • 21. Distal ischemia with digital gangrene secondary to Buerger's disease.
    Lance BJ; Kirschenbaum SE
    J Foot Surg; 1991; 30(6):534-41. PubMed ID: 1770204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Buerger's disease affecting mesenteric arteries: a rare cause of intestinal ischemia--a case report.
    Siddiqui MZ; Reis ED; Soundararajan K; Kerstein MD
    Vasc Surg; 2001; 35(3):235-8. PubMed ID: 11452353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Buerger's disease: diagnosis and management.
    Shionoya S
    Cardiovasc Surg; 1993 Jun; 1(3):207-14. PubMed ID: 8076031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Buerger's disease in the modern era.
    Mills JL; Taylor LM; Porter JM
    Am J Surg; 1987 Jul; 154(1):123-9. PubMed ID: 3605510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Buerger's disease or Buerger's syndrome? An analysis of 12 cases.
    Scharf GM; van Wyk FA; Cloete GN; Rautenbach BK
    S Afr Med J; 1986 Dec; 70(13):803-5. PubMed ID: 3798265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Buerger's disease in a 19-year-old woman.
    Matsushita M; Kuzuya A; Kobayashi M; Nishikimi N; Ito M; Oba Y; Yano T; Komori K
    J Vasc Surg; 2003 Jul; 38(1):175-9. PubMed ID: 12844108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Buerger's syndrome.
    Herman BE
    Angiology; 1975 Nov; 26(10):713-6. PubMed ID: 1053580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endovascular Treatment of Thromboangiitis Obliterans (Buerger's Disease).
    Modaghegh MS; Hafezi S
    Vasc Endovascular Surg; 2018 Feb; 52(2):124-130. PubMed ID: 29237360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-Term Outcome and Prognostic Factors of Complications in Thromboangiitis Obliterans (Buerger's Disease): A Multicenter Study of 224 Patients.
    Le Joncour A; Soudet S; Dupont A; Espitia O; Koskas F; Cluzel P; Hatron PY; Emmerich J; Cacoub P; Resche-Rigon M; Lambert M; Saadoun D;
    J Am Heart Assoc; 2018 Dec; 7(23):e010677. PubMed ID: 30571594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic criteria of Buerger's disease.
    Shionoya S
    Int J Cardiol; 1998 Oct; 66 Suppl 1():S243-5; discussion S247. PubMed ID: 9951826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic angiogenesis in Buerger's disease (thromboangiitis obliterans) patients with critical limb ischemia by autologous transplantation of bone marrow mononuclear cells.
    Motukuru V; Suresh KR; Vivekanand V; Raj S; Girija KR
    J Vasc Surg; 2008 Dec; 48(6 Suppl):53S-60S; discussion 60S. PubMed ID: 19084740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Buerger's disease with intestinal involvement.
    Iwai T
    Int J Cardiol; 1998 Oct; 66 Suppl 1():S257-63; discussion S265. PubMed ID: 9951828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coronary artery disease in patients with Buerger's disease.
    Hong TE; Faxon DP
    Rev Cardiovasc Med; 2005; 6(4):222-6. PubMed ID: 16379018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Buerger's disease and anticardiolipin antibodies.
    Pereira de Godoy JM; Braile DM
    J Cardiovasc Med (Hagerstown); 2009 Oct; 10(10):792-4. PubMed ID: 19455050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic angiogenesis in Buerger's disease: reviewing the treatment landscape.
    Ribieras AJ; Ortiz YY; Liu ZJ; Velazquez OC
    Ther Adv Rare Dis; 2022; 3():26330040211070295. PubMed ID: 37180424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arterial obstruction of the upper limb in Buerger's disease: its incidence and primary lesion.
    Hirai M; Shionoya S
    Br J Surg; 1979 Feb; 66(2):124-8. PubMed ID: 420983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase IV postmarketing surveillance study shows continued efficacy and safety of Stempeucel in patients with critical limb ischemia due to Buerger's disease.
    Gupta PK; Dutta S; Kala S; Nekkanti M; Desai SC; Mahapatra SS; Dhar A; Raju R; M R; Behera A; P S; Raviraja NS; Viswanathan P; Chandrashekar M; Thej C; K V P; Abraham J; Boggarapu H; Udaykumar K
    Stem Cells Transl Med; 2021 Dec; 10(12):1602-1613. PubMed ID: 34519179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seasonal variation of Buerger's disease in Northern part of Thailand.
    Laohapensang K; Rerkasem K; Kattipattanapong V
    Eur J Vasc Endovasc Surg; 2004 Oct; 28(4):418-20. PubMed ID: 15350566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ADAM10 inhibits the interaction between IL-17 and HMGB1 in Buerger's disease.
    Byun JK; Kim KH; Rha SW; Park Y; Cha JA; Choi SY; Choi BG; Choi CU
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(11):4051-4063. PubMed ID: 34156683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesenteric Buerger's disease.
    Cho YP; Kwon YM; Kwon TW; Kim GE
    Ann Vasc Surg; 2003 Mar; 17(2):221-3. PubMed ID: 12632269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.